PMV Pharmaceuticals, Inc. (PMVP)
NASDAQ: PMVP · Real-Time Price · USD
1.305
+0.025 (1.95%)
Jul 21, 2026, 11:59 AM EDT - Market open
PMV Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, PMV Pharmaceuticals stock has a consensus rating of "Strong Buy" and an average price target of $4.00. The average 1-year stock price forecast is 206.51% higher than the current stock price, while the lowest is $3.00 (+129.89%) and the highest is $5.00 (+283.14%).
Price Target: $4.00 (+206.51%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for PMV Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 5 | 5 | 4 | 5 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 5 | 5 | 4 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Ladenburg Thalmann & Co. No rating | Ladenburg Thalmann & Co. | Buy Initiates $3 | Buy | Initiates | $3 | +129.89% | Jul 8, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $6 → $5 | Buy | Maintains | $6 → $5 | +283.14% | May 13, 2026 |
| TD Cowen | TD Cowen | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 12, 2026 |
| Evercore ISI | Evercore ISI | Buy Maintains $16 → $4 | Buy | Maintains | $16 → $4 | +206.51% | Apr 13, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
3.15M
EPS This Year
-1.52
from -1.48
EPS Next Year
-1.09
from -1.52
EPS and Forward PE are based on non-GAAP adjusted numbers.